A multicentre, randomised, open-label study comparing the efficacy & safety of once daily (O.D) ORG31540/SR90107a versus adjusted dose intravenous (I.V) unfractioned heparin (UFH) In the initial treat

  • Narayan, Kam (Primary Chief Investigator (PCI))
  • Leyden, Michael (Chief Investigator (CI))
  • Rosengarten, Andrew (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/01 → 30/04/02